Found 686 matching trials
CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
PHASE2The objective of this study is to assess the efficacy, safety, and tolerabi...
Location
CYS-003 Investigational Site
Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones
PHASE1The objectives of the study are to assess the systemic exposure, safety and...
Location
University of California Irvine Medical Center
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).
PHASE2This is a Phase 2, multi-site, double-masked, randomized, vehicle-controlle...
Location
GC2302 Study Site 110
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
PHASE2Phase 2 study to assess the efficacy of topically administered eyedrops of ...
Safety and Efficacy of Moxidex Otic
PHASE3The purpose of this study is to determine if Moxidex otic solution is safe ...
Location
Contact Alcon Call Center for Trial Locations
Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
PHASE2The purpose of this study is to determine if Levulan Photodynamic Therapy (...
Location
UCSD Dermatology Perlman Ambulatory Clinic
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
PHASE3This study is being done to find out if an investigational product called H...
Location
Multiple Locations
Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop
PHASE1This is a Two-Stage Phase 1/2 study to evaluate the safety, tolerability an...
SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.
PHASE3A Phase 3, randomized, double-masked, vehicle-controlled trial to evaluate ...
Location
UAB Department of Ophthalmology
The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)
PHASE2The purpose of this trial is to compare the ability of two doses of OT-551 ...
Location
Multiple Locations